India to Peru: Rituximab Export Trade Route
India has recorded 17 verified shipments of Rituximab exported to Peru, representing a combined trade value of $371.3K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $21.8K USD. The leading Indian exporter is RELIANCE LIFE SCIENCES PRIVATE LIMITED, which accounts for 79% of total export value with 12 shipments worth $292.8K USD. On the buying side, DROGUERIA MK LAB S.A.C is the largest importer in Peru with $243.6K USD in purchases. The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, HETERO BIOPHARMA LIMITED, R L PHARMA — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Peru Rituximab corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $371.3K USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's rituximab manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $21.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with rituximab's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #8 among India's top rituximab export destinations globally.
On the import side, key buyers of Indian rituximab in Peru include DROGUERIA MK LAB S.A.C, XXVENXXHARXX S XXC, DROGUERIA MK LAB SAC and 1 others. DROGUERIA MK LAB S.A.C is the single largest importer with 2 shipments valued at $243.6K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#8
- Annual growth+26.8%
- Demand growth+22.5%
- Regulatory ease73/100
Top 10 Indian Rituximab Exporters to Peru
Showing top 10 of 3 Indian suppliers exporting Rituximab to Peru, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $24.4K per shipment | 12 | $292.8K | 78.9% |
| 2 | HETERO BIOPHARMA LIMITED Avg $38.1K per shipment | 2 | $76.3K | 20.5% |
| 3 | R L PHARMA Avg $750 per shipment | 3 | $2.3K | 0.6% |
This table shows the top 10 of 3 Indian companies exporting rituximab to Peru, ranked by total trade value. The listed exporters are: RELIANCE LIFE SCIENCES PRIVATE LIMITED, HETERO BIOPHARMA LIMITED, R L PHARMA. RELIANCE LIFE SCIENCES PRIVATE LIMITED is the dominant supplier with 12 shipments worth $292.8K USD, giving it a 79% market share.
Top 10 Rituximab Importers in Peru
Showing top 10 of 4 known buyers in Peru receiving Rituximab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rituximab in Peru include DROGUERIA MK LAB S.A.C, XXVENXXHARXX S XXC, DROGUERIA MK LAB SAC, JULIO CSAR ASENCIOS MEJA. The largest importer is DROGUERIA MK LAB S.A.C, accounting for $243.6K USD across 2 shipments — representing 66% of all rituximab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DROGUERIA MK LAB S.A.C | 2 | $243.6K | 65.6% |
| 2 | XXVENXXHARXX S XXC | 2 | $76.3K | 20.5% |
| 3 | DROGUERIA MK LAB SAC | 10 | $49.2K | 13.2% |
| 4 | JULIO CSAR ASENCIOS MEJA | 3 | $2.3K | 0.6% |
Top 10 Rituximab Formulations Imported by Peru
Showing top 10 of 10 product formulations shipped on the India to Peru Rituximab route, ranked by trade value
Peru imports a wide range of rituximab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — RITUXIMAB 500MG (RITUXIREL 500MG) — accounts for $214.9K USD across 1 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RITUXIMAB 500MG (RITUXIREL 500MG) | 1 | $214.9K | 57.9% |
| 2 | RITUXIMAB (RILAST)500 MG/50ML VIAL(1X1S) | 2 | $76.3K | 20.5% |
| 3 | RITUXIMAB INJECTION RDNA ORIGIN500MG RITUXIREL 500MG | 2 | $36.9K | 9.9% |
| 4 | RITUXIMAB 100MG (RITUXIREL 100MG) | 1 | $28.7K | 7.7% |
| 5 | RITUXIMAB INJECTION RDNA ORIGIN100MG RITUXIREL 100MG | 2 | $12.3K | 3.3% |
| 6 | PHARMACEUTICALS PRODUCTS MABALL 500 MG INJ RITUXIMABNOS | 2 | $1.2K | 0.3% |
| 7 | PHARMACEUTICALS PRODUCTS MABALL 100MG INJ RITUXIMABNOS | 1 | $1.0K | 0.3% |
| 8 | FOC RITUXIMAB INJECTION 100MG DELIVERCHALLAN NO.27155000001547/26.10.2023 IGST VIDE ARN NO.AD2702230153796 VALID UOTP | 2 | $0 | 0.0% |
| 9 | FOC RITUXIMAB INJECTION 500 MG DELIVERCHALLAN NO.27155000001548/26.10.2023 IGST VIDE ARN NO.AD2702230153796 VALID UOT | 2 | $0 | 0.0% |
| 10 | FOC RITUXIMAB INJECTION 100 MG DELIVERCHALLAN NO.27155000001725/17.11.2023 IGST VIDE ARN NO.AD2702230153796 VALID UPT | 2 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 13 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's rituximab exports to Peru are driven primarily by a handful of large-scale manufacturers. RELIANCE LIFE SCIENCES PRIVATE LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, HETERO BIOPHARMA LIMITED, R L PHARMA — together account for 100% of total trade value on this route. The average shipment value of $21.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as rituximab (rilast)500 mg/50ml vial(1x1s) and rituximab injection rdna origin500mg rituxirel 500mg, suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DROGUERIA MK LAB S.A.C is the largest importer with 2 shipments worth $243.6K USD — representing 66% of all rituximab imports from India on this route.
Route Statistics
- Trade Volume
- $371.3K
- Avg. Shipment
- $21.8K
- Suppliers
- 3
- Buyers
- 4
- Transit (Sea)
- ~18 days
- Annual Growth
- +26.8%
Other Rituximab Routes
Unlock the Full India to Peru Rituximab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 17 shipments on this route.
Frequently Asked Questions — India to Peru Rituximab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rituximab to Peru?
The leading Indian exporters of Rituximab to Peru are RELIANCE LIFE SCIENCES PRIVATE LIMITED, HETERO BIOPHARMA LIMITED, R L PHARMA. RELIANCE LIFE SCIENCES PRIVATE LIMITED holds the largest market share at approximately 79% of total trade value on this route.
Q What is the total value of Rituximab exports from India to Peru?
India exports Rituximab to Peru worth approximately $371.3K USD across 17 recorded shipments. The average value per shipment is $21.8K USD.
Q Which ports does India use to ship Rituximab to Peru?
The most active port of origin is SAHAR AIR with 13 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Peru for Rituximab?
The average transit time for Rituximab shipments from India to Peru is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Peru Rituximab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.8% with demand growth tracking at 22.5%. The route is ranked #8 among India's top Rituximab export destinations globally.
Q How many suppliers are active on the India to Peru Rituximab route?
There are currently 3 active Indian suppliers exporting Rituximab to Peru. The market is moderately concentrated with RELIANCE LIFE SCIENCES PRIVATE LIMITED accounting for 79% of total shipment value.
Q Who are the main importers of Rituximab from India in Peru?
The leading importers of Indian Rituximab in Peru include DROGUERIA MK LAB S.A.C, XXVENXXHARXX S XXC, DROGUERIA MK LAB SAC, JULIO CSAR ASENCIOS MEJA. DROGUERIA MK LAB S.A.C is the largest buyer with 2 shipments worth $243.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Peru export trade corridor identified from Indian Customs (DGFT) records for Rituximab.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 4 importers in Peru matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 17 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists